Skip to content

Clinical trials

Completed Neoplasms trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Status: Completed Country / region: Hong Kong Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20074
20083
20092
20104
20113
20121
20131
20145
20153
20162
20174
20184
20195
20201
20213
20222
20234
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of Hong Kong10
Chinese University of Hong Kong4
Novartis Pharmaceuticals4
Bayer3
Hoffmann-La Roche3
The Hong Kong Polytechnic University3
Bio-Cancer Treatment International Limited2
BioAtla, Inc.2
GlaxoSmithKline2
Sanofi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms58
Carcinoma, Hepatocellular8
Carcinoma, Non-Small-Cell Lung7
Neoplasm Metastasis6
Neoplasms by Site6
Breast Neoplasms5
Carcinoma5
Neoplasms by Histologic Type5
Adenocarcinoma4
Digestive System Diseases4

Trials

Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.